Cell Growth & Differentiation, Vol 1, Issue 9 407-420, Copyright © 1990 by American Association of Cancer Research

ARTICLES

Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation

F Ciardiello, ML McGeady, N Kim, F Basolo, N Hynes, BC Langton, H Yokozaki, T Saeki, JW Elliott and H Masui
Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892.

MCF-10A cells are a spontaneously immortalized normal human mammary epithelial cell line. MCF-10A cells were transfected with two expression vector plasmids containing either a human point-mutated c-Ha-ras protooncogene or the rat c-neu protooncogene. c-Ha-ras-transfected MCF-10A cells grow as colonies in soft agar, exhibit a 3- to 4-fold increase in their growth rate in serum-free medium, and show a reduced mitogenic response to exogenous epidermal growth factor (EGF) or transforming growth factor-alpha (TGF alpha) as compared to MCF-10A cells. c-Ha-ras-transfected MCF-10A cells express a 4- to 8-fold increase in TGF alpha mRNA levels and secrete 4- to 6-fold more TGF alpha protein as compared to MCF-10A cells. Addition of either an anti-TGF alpha neutralizing monoclonal antibody or an anti-EGF receptor blocking monoclonal antibody to the Ha-ras-transformed MCF-10A cells produces a 50 to 80% inhibition of colony formation of these cells in soft agar. c-neu-transfected MCF-10A cells grown in soft agar and exhibit an increase in their growth rate in serum-free medium at a level comparable to that observed in Ha-ras-transformed MCF-10A cells. Addition of an anti-c-erbB-2 monoclonal antibody inhibits the anchorage-independent growth of these cells in soft agar. However, c-neu-transformed MCF-10A cells show no increase in TGF alpha secretion and no change in their responsiveness to exogenous EGF or TGF alpha. A recombinant retroviral vector containing the human TGF alpha gene was also introduced into MCF-10A cells. TGF alpha-infected MCF-10A cells secrete 15- to 20-fold more TGF alpha protein than MCF-10A cells, form colonies in soft agar, exhibit an enhanced growth rate in serum-free medium, and show a decreased mitogenic response to exogenous EGF or TGF alpha at a level equivalent to Ha-ras-transformed MCF-10A cells. Growth of TGF alpha-infected MCF-10A cells in soft agar is completely inhibited by anti-TGF alpha neutralizing or anti-EGF receptor blocking monoclonal antibodies. These results suggest that TGF alpha is an intermediary in the transformation of human mammary epithelial cells by an activated c-Ha-ras gene, but not by the c-neu gene, and demonstrate that overexpression of this growth factor is able to transform immortalized human mammary epithelial cells which also express a sufficient complement of functional EGF receptors.

This article has been cited by other articles:

				A. Ruiz-Saenz, C. Dreyer, M. R. Campbell, V. Steri, N. Gulizia, and M. M. Moasser HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3 Cancer Res., July 1, 2018; 78(13): 3645 - 3658. [Abstract] [Full Text] [PDF]

				J. Acquaviva, H. J. Jun, J. Lessard, R. Ruiz, H. Zhu, M. Donovan, S. Woolfenden, A. Boskovitz, A. Raval, R. T. Bronson, et al. Chronic Activation of Wild-Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation Cancer Res., December 1, 2011; 71(23): 7198 - 7206. [Abstract] [Full Text] [PDF]

				J. Y. Cha, Q. T. Lambert, G. W. Reuther, and C. J. Der Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis Mol. Cancer Res., March 1, 2008; 6(3): 435 - 445. [Abstract] [Full Text] [PDF]

				H. Konishi, B. Karakas, A. M. Abukhdeir, J. Lauring, J. P. Gustin, J. P. Garay, Y. Konishi, E. Gallmeier, K. E. Bachman, and B. H. Park Knock-in of Mutant K-ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K-ras Mediated Transformation Cancer Res., September 15, 2007; 67(18): 8460 - 8467. [Abstract] [Full Text] [PDF]

				F. Ciardiello, R. Caputo, V. Damiano, R. Caputo, T. Troiani, D. Vitagliano, F. Carlomagno, B. M. Veneziani, G. Fontanini, A. R. Bianco, et al. Antitumor Effects of ZD6474, a Small Molecule Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, with Additional Activity against Epidermal Growth Factor Receptor Tyrosine Kinase Clin. Cancer Res., April 1, 2003; 9(4): 1546 - 1556. [Abstract] [Full Text] [PDF]

				A. Schulze, K. Lehmann, H. B.J. Jefferies, M. McMahon, and J. Downward Analysis of the transcriptional program induced by Raf in epithelial cells Genes & Dev., April 15, 2001; 15(8): 981 - 994. [Abstract] [Full Text]

				A. E. G. Lenferink, J. F. Simpson, L. K. Shawver, R. J. Coffey, J. T. Forbes, and C. L. Arteaga Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice PNAS, August 15, 2000; 97(17): 9609 - 9614. [Abstract] [Full Text] [PDF]

				F. Ciardiello, R. Caputo, R. Bianco, V. Damiano, G. Pomatico, S. De Placido, A. R. Bianco, and G. Tortora Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human Cancer Cells by ZD-1839 (Iressa), an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor Clin. Cancer Res., May 1, 2000; 6(5): 2053 - 2063. [Abstract] [Full Text] [PDF]

				R. Lu and G. Serrero Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468 PNAS, April 11, 2000; 97(8): 3993 - 3998. [Abstract] [Full Text] [PDF]

				M. Alimandi, L.-M. Wang, D. Bottaro, C.-C. Lee, A. Kuo, M. Frankel, P. Fedi, C. Tang, M. Lippman, and J. H. Pierce Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors EMBO J., September 15, 1997; 16(18): 5608 - 5617. [Abstract] [Full Text] [PDF]

				L. M. Gangarosa, N. Sizemore, R. Graves-Deal, S. M. Oldham, C. J. Der, and R. J. Coffey A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells J. Biol. Chem., July 25, 1997; 272(30): 18926 - 18931. [Abstract] [Full Text] [PDF]

				S A McCarthy, M L Samuels, C A Pritchard, J A Abraham, and M McMahon Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes & Dev., August 15, 1995; 9(16): 1953 - 1964. [Abstract] [PDF]

				P. Buse, P. L. Woo, D. B. Alexander, H. H. Cha, A. Reza, N. D. Sirota, and G. L. Firestone Transforming Growth Factor-{alpha} Abrogates Glucocorticoid-stimulated Tight Junction Formation and Growth Suppression in Rat Mammary Epithelial Tumor Cells J. Biol. Chem., March 24, 1995; 270(12): 6505 - 6514. [Abstract] [Full Text] [PDF]

				A. E. G. Lenferink, J. F. Simpson, L. K. Shawver, R. J. Coffey, J. T. Forbes, and C. L. Arteaga Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice PNAS, August 15, 2000; 97(17): 9609 - 9614. [Abstract] [Full Text] [PDF]